Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation (Q28285888)

Europe PubMed Central

title

Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation (English)

0 references

author

Wesley C Van Voorhis

5

0 references

Michael H. Gelb

4

Michael H Gelb

0 references

Frederick S Buckner

2

Frederick S Buckner

0 references

Kohei Yokoyama

3

Kohei Yokoyama

0 references

Richard T Eastman

1

Journal of Lipid Research

Richard T Eastman

0 references

language of work or name

English

0 references

publication date

February 2006

0 references

published in

0 references

volume

47

0 references

page(s)

233-40

0 references

issue

2

0 references

cites work

Chemoresistance in falciparum malaria

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Protein prenyl transferase activities of Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Protein farnesyltransferase and protein prenylation in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Blocked pathways: FTIs shut down oncogene signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Protein farnesyltransferase inhibitors exhibit potent antimalarial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

21 January 2018

Fosmidomycin for malaria

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Prenyl proteins in eukaryotic cells: a new type of membrane anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Recent advances in the study of prenylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

p21ras is modified by a farnesyl isoprenoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Identification of Ras farnesyltransferase inhibitors by microbial screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Cloning, heterologous expression, and substrate specificities of protein farnesyltransferases from Trypanosoma cruzi and Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Molecular Cloning and Characterization of a Protein Farnesyltransferase from the Enteric Protozoan Parasite Entamoeba histolytica

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Cloning, heterologous expression, and distinct substrate specificity of protein farnesyltransferase from Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Characterization of farnesylated protein tyrosine phosphatase TcPRL-1 from Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

TcRho1, a farnesylated Rho family homologue from Trypanosoma cruzi: cloning, trans-splicing, and prenylation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

A bioinformatic analysis of the RAB genes of Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Directed library of anilinogeranyl analogues of farnesyl diphosphate via mixed solid- and solution-phase synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Tools to analyze protein farnesylation in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Characterization of protein geranylgeranyltransferase I from the enteric protist Entamoeba histolytica

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.R500016-JLR200

10.1194/JLR.R500016-JLR200

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4194837

4194837

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference